Cite
APA Citation
Young, R., Poyser, C., Crack, L., Dockrell, D., Bowman, C., Billingham, L., Bower, M., Westwell, S., Leahy, M., & Woll, P. (n.d.). 3434 A UK national phase I/II clinical trial of a MEK1/2 inhibitor combined with highly active anti-retroviral therapy for HIV-associated Kaposi's sarcoma. European journal of cancer, 51, S699–. http://access.bl.uk/ark:/81055/vdc_100030687863.0x000020